SCHEMBL6734102

SCHEMBL6734102

COCCOc1ccc2[nH]cc(C(=O)O)c2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAG1 P54619 3/20 0.46
PRKAA1 Q13131 3/20 0.46
PRKAB1 Q9Y478 3/20 0.46
PRKAB2 O43741 1/20 0.46
PRKAA2 P54646 1/20 0.46
PRKAG3 Q9UGI9 1/20 0.46
PRKAG2 Q9UGJ0 1/20 0.46
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
HTT P42858 1/20 0.40
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7231610 0.91 HTT (0.46) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL6728722 0.85 MAPT (0.44) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL6722084 0.85 PIM1 (0.48) MTNR1AMTNR1BHTTKDM4EHSD17B10
SCHEMBL6729681 0.84 PIM1 (0.43) MTNR1AMTNR1BHTTKDM4EHSD17B10
SCHEMBL6722059 0.84 ALDH1A1 (0.43) MTNR1AMTNR1BHTTKDM4EHSD17B10
SCHEMBL6726958 0.84 KDM4E (0.39) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL30267364 0.83 MTNR1A (0.53) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL6667683 0.83 MTNR1A (0.53) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL6724529 0.83 PIM1 (0.41) MTNR1AMTNR1BHTTKDM4EHSD17B10
SCHEMBL30089349 0.81 MTNR1A (0.42) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US disclosed